U.S. financial markets will be closed on Monday, Sept. 4 in observance of Labor Day. Because Labor Day is a Federal holiday, banks and federal government offices will be shuttered.
On Friday, however, Wall Street will be open during normal trading hours, though expect slightly thinner volumes, as many will plan an earlier exit from trading desks ahead of a long weekend. (That said, more than a few market geeks will be eagerly anticipating the latest batch of closely watched employment report for August and a few other key economic reports on Friday before ducking out).
Top Safest Stocks To Invest In Right Now: TiGenix NV (TGXSF)
- [By SEEKINGALPHA.COM]
Leuven, Belgium-based Tigenix (OTC:TGXSF) filed to go public in the U.S. in late 2015, only to become entangled with Bavarian Nordic (OTC:BVNKF) and Basilea Pharmaceutica (OTC:BPMUF) as the European drugmakers pulled back from NASDAQ. Tigenix subsequently increased its bank account following a 23.75 million placement in Belgium, and added an additional 25 million via a relationship with Takeda, before coming back to Wall Street in October 2016 with a revamped slate of underwriters.
Top Safest Stocks To Invest In Right Now: American Tower Corporation (REIT)(AMT)
- [By WWW.THESTREET.COM]
American Tower (AMT) : “This is the best in the business and is worth owning, even if the chart looks terrible.”
Mattel (MAT) : “I think you’re OK but I prefer Hasbro (HAS) for growth.”
Top Safest Stocks To Invest In Right Now: iShares MSCI Europe Financials Sector Index Fund(EUFN)
- [By Wayne Duggan]
Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).
Top Safest Stocks To Invest In Right Now: Catabasis Pharmaceuticals, Inc.(CATB)
- [By Lisa Levin]
Shares of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) got a boost, shooting up 46 percent to $6.52. Catabasis Pharmaceuticals and Sarepta Therapeutics Inc (NASDAQ: SRPT) reported a joint research collaboration in Duchenne Muscular Dystrophy.